Insu Therapeutics is redefining diabetes treatment with a groundbreaking non-invasive insulin delivery technology, to relieve the discomfort of traditional injections and enhance patient experiences for over 9 million type 1 diabetics and the broader needs of over half a billion people with diabetes globally.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.insutherapeutics.com
- Keywords
- Show more similar pages.
Insu Therapeutics Questions
Insu Therapeutics's website is http://www.insutherapeutics.com
Insu Therapeutics's LinkedIn profile is https://www.linkedin.com/company/insutherapeutics
Insu Therapeutics's industry is
Biotechnology Research
Insu Therapeutics's top competitors are
Lunar Therapeutics,
Sora Fuel,
Arrowsmith Genetics,
Melius Microbiomics,
Nphyla,
Cerecura Nanotherapeutics,
Amphoraxe Life Sciences Inc.,
Smartparent Mobile Health Inc.,
Sustainable Bioproduct Innovations,
Sinedore Medicine 正弦生醫.
Insu Therapeutics's categories are Biotechnology Research
